Article
Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer.
The pharmacogenomics journal - 1 Sept 2018
Suenaga Mitsukuni, Schirripa Marta, Cao Shu, Zhang Wu, Yang Dongyun, Cremolini Chiara, Lonardi Sara, Bergamo Francesca, Ning Yang, Yamamoto Noriko, Okazaki Satoshi, Berger Martin D, Miyamoto Yuji, Gopez Roel, Barzi Afsaneh, Yamaguchi Toshiharu, Stintzing Sebastian, Heinemann Volker, Loupakis Fotios, Falcone Alfredo, Lenz Heinz-Josef
Abstract excerpt
PIN1-mediated substrate isomerization plays a role in the repair of DNA double-strand breaks. We hypothesized that genetic polymorphisms in PIN1-related pathways may affect tumor sensitivity to oxaliplatin or irinotecan in metastatic colorectal cancer (mCRC) patients. We analyzed genomic DNA from five cohorts of mCRC patients (total 950) treated with different first-line treatments: oxaliplatin cohorts 1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
